

Haryana’s adults carry more diabetes than the national average, 12.4% against 11.4%, according to the Haryana arm of the ICMR-INDIAB study. For anyone weighing a cardiac diabetic PCD franchise in Haryana, that figure settles one question: the patients are there. It can’t tell you whether a particular company, district or licence setup will turn those patients into prescriptions for you.
This guide covers what the state’s own surveys say about demand, then the drug licences you need and where those rules are still moving. The last part lists the papers to ask any manufacturer for before you sign. Novalab Cardiac & Diabetic Care is based in Panchkula, so Haryana is its home market.
Table of Contents
ToggleTwo surveys do most of the work, and they measure different things.
The ICMR-INDIAB team sampled Haryana between December 2018 and July 2019. Diabetes showed up in 17.9% of urban adults and 9.5% of rural adults. Prediabetes was more common still, at 18.2% across the state against 15.3% nationally. The same study found diabetes concentrated among overweight and hypertensive adults, so a diabetologist’s waiting room doubles as a hypertension clinic. That is the practical case for carrying both ranges from one company.
The state’s STEPS survey, run by PGIMER Chandigarh, looked at what happens after diagnosis, and that’s where the numbers get uncomfortable. Among Haryana adults aged 18 to 69, 26.2% had hypertension. Of those, 33.4% knew it, 26.3% were on treatment and 12% had their pressure under control. For diabetes (15.1% of the sample), 29.5% knew, 22.4% were on treatment and 13.8% were controlled. And 74% of respondents had never had their blood glucose measured (Frontiers in Public Health, 2022).
That gap between diagnosis and control is the real business case. The same patient needs the same tablet for years, so repeat orders go to the brand that stays in stock and the representative who keeps visiting, not to whoever offers the biggest launch discount.
Treat the figures with some care. Both surveys were fielded in the second half of the 2010s, so they predate today’s numbers. Methods differ too: the national family health survey (NFHS-5) puts diabetes near 6.5%, which the INDIAB authors attribute to its use of random glucose readings instead of fasting and post-meal tests. And disease burden is not a sales forecast. Your sales depend on who prescribes your brand.
Several pages that rank for this phrase give reasons to join, such as exclusive territory, low investment and supportive state policy, without citing a single Haryana figure. The data above is the part they skip.
Haryana has 22 districts, and 14 of them sit inside the National Capital Region. The INDIAB team split its results along that line. Urban NCR had the highest diabetes rate, 19.5%, against 14.0% in urban districts outside the NCR. Rural areas sat closer together: 9.7% inside the NCR and 8.9% outside. Prediabetes peaked outside the NCR, at 19.5% in rural districts and 19.4% in urban ones.
One reading, and it’s a judgement rather than a finding: NCR cities such as Gurugram and Faridabad offer more patients per square kilometre and also more rival brands and PCD companies. Towns outside the NCR have fewer prescribers, but their prediabetes pool should feed diabetes prescriptions over the next few years.
Your own contacts probably matter more than either. A partner who already knows the physicians in Ambala is better placed there than in Gurugram, whatever a prevalence table says.
Novalab has separate guides for Panchkula and Ambala, a page on the wider Tricity under Chandigarh, and one for Delhi if Gurugram or Faridabad is on your list.
Most partners who stock medicines and supply chemists hold a wholesale licence. Form 20B covers general allopathic drugs, and Form 21B covers drugs listed in Schedules C and C(1). The Delhi Drugs Control Department lists the forms, which come from the central Drugs Rules, so Haryana uses the same ones. You apply on Form 19 to the state licensing authority. Retail chemists hold Form 20 and 21 instead.
Novalab’s catalogue is tablets and capsules, so ask the Haryana licensing office which forms your product list needs.
The premises must cover at least ten square metres and sit in the charge of a competent person (Rule 64 text). For a wholesale licence, that person can be a registered pharmacist or someone who meets Rule 64’s other conditions. Today those are a matriculate with four years in the drug trade, or a graduate with one year (Medical Dialogues).
That second condition is the unsettled part. The Drugs Technical Advisory Board has pushed since 2015 to limit wholesale competent persons to pharmacy qualifications: D.Pharm, B.Pharm, M.Pharm, Pharm.D or registered pharmacist. A draft notification followed in December 2016 and drew heavy opposition. When the board reaffirmed its recommendation in October 2024, the Centre was still collecting comments, and the board wanted people already registered to be protected. No final notification turned up in the sources checked for this article, so confirm the current position with the licensing office before you hire. If you’re hiring now, a pharmacist costs a little more and removes the risk if the rule tightens.
Novalab’s own conditions, stated on its site, are a drug licence, GST registration, willingness to meet the minimum order and investment requirements, with experience given priority. The franchise checklist walks through the paperwork.
Revised Schedule M, India’s updated manufacturing standard, was due for every pharma unit from 1 January 2026 once the last extension for smaller firms ran out (Business Standard). WHO-GMP is a separate certificate, and not everyone holds it. In March 2025, about 2,000 of roughly 8,500 MSME pharma units did (Business Standard). ISO 9001:2015, which Novalab also lists, certifies a quality management system. It doesn’t approve any single medicine.
So a franchise company should hand you four things without fuss: its current WHO-GMP certificate with the expiry date, the manufacturing site’s revised Schedule M status, approval details for each formulation you’ll promote, and territory terms in writing, with district names, products covered, duration and renewal.
Novalab’s site states ISO 9001:2015 and WHO-GMP certification. Ask for copies, as you would from any company. The WHO-GMP explainer and the guide to choosing a PCD company go further on what to check.
According to the company’s franchise FAQ, partners get exclusive rights in their allotted area, so no other Novalab franchise works the same patch. They also get free promotional material: literature, visual aids, samples and diaries. The range covers antiarrhythmics, antihypertensives, antiplatelets and anticoagulants, oral antidiabetics and chest pain medicines.
Examples include Empacred M (empagliflozin with metformin) and Olmedeys-A (olmesartan with amlodipine) on the tablet side, and Dabikast-150 (dabigatran) among the capsules. Packaging uses Alu Alu, blister, foil and carton. The full list sits on the products page.
Start with a short product list matched to the doctors you know, not the whole catalogue. Exclusive territories also depend on availability, so confirm your district before you plan around it. The company’s comparison of cardiac diabetic franchise companies explains what monopoly rights do and don’t cover, and its shorter Haryana overview gives the company side.
This will close in 0 seconds